Neurology Updates

Neurology Updates

Here you will find regular scientific news from our Scientific Panels. We cover all areas of neurology, including rare diseases. The most recent news are displayed below. You will find all news of different areas sorted into the subsections of the respective scientific panel. Enjoy reading!

Process for SP Submissions

If you want to submit a neurology update for your scientific panel, please find related information here:

| COVID-19 | Epilepsy  

Epilepsy care during the COVID-19 pandemic

Telemedicine can help to deliver epilepsy care during the COVID-19 pandemic. Careful planning is needed to protect patients and healthcare workers…

more...

Created by Bruna NUCERA (Franz Tappeiner Hospital, Merano, Italy) and Ronan McGinty

| COVID-19 | Epilepsy  

Acute symptomatic seizures and SARS-CoV-2 encephalitis in COVID-19

Acute symptomatic seizures have been reported with SARS-CoV-2-positive meningoencephalitis but, overall, seizures seem uncommon with SARS-CoV-2…

more...

Created by Guillermo Delgado-García (Instituto Nacional de Neurología y Neurocirugía, México) and Ronan McGinty

| Epilepsy  

New randomised control trial evidence for treatment of status epilepticus

Status epilepticus (SE) remains life thereatening condition with limited therepautic options. Benzodiazepine-refractory, or established, SE is thought…

more...

Created by Prof. Konrad Rejdak; Department of Neurology; Medical University of Lublin, Poland

| Epilepsy  

Adjunctive cenobamate for uncontrolled focal epilepsy in adults: phase II trial results

A double-blind, randomised, placebo-controlled phase II study of adjunctive cenobamate in adults with uncontrolled focal epilepsy showed high rates of…

more...

Created by Ronan N McGinty (Epilepsy Clinical Fellow, Nuffield Department of Clinical Neurosciences, Oxford University)

| COVID-19 | Epilepsy  

Caring for epilepsy patients in the face of a pandemic

This neurology update summarises key points on caring for people with epilepsy during the COVID-19 pandemic.

more...

Created by Ayse Deniz ELMALI (Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Clinical Neurophysiology; Istanbul, TURKEY) and Ronan McGinty

| COVID-19 | Epilepsy  

Seizures as a Feature of COVID-19

Seizures appear to be a rare feature of COVID-19. Avoiding unintentional antiseizure medicine withdrawal during the COVID-19 pandemic is a potential…

more...

Created by Dr. Axel Ferreira (Neurology Resident at Hospital Pedro Hispano, Portugal) and Ronan McGinty

| COVID-19 | Epilepsy  

Impact of COVID-19 on management of epilepsy

Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is causing…

more...

Created by Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli

| Epilepsy  

New treatment options for pediatric convulsive status epilepticus after failure of first-line benzodiazepines

There are limited options as second line treatment in convulsive status epilepticus (CSE), both in underage and adult populations with sufficient…

more...

Created by Prof. Konrad Rejdak; Department of Neurology; Medical University of Lublin, Poland

| Epilepsy  

Levetiracetam and NOACs

In patient with post stroke epilepsy and non-valvular atrial fibrillation, the combination of levetiracetam and NOACs is very valuable. Therapeutic…

more...

Created by Kälviäinen, Reetta K, Kuopio, Finland; Rubboli, Guido, Dianalund, Denmark; Bornstein, Nathan, Israel; Markus, Hugh, Cambridge, UK

| Epilepsy  

Seizure detection using wearable devices

There is need for automated seizure detection using wearable devices, to decrease the morbidity and mortality associated with seizures, especially…

more...

Created by Sándor Beniczky, Danish Epilepsy Centre and Aarhus University Hospital, Denmark

| Epilepsy | Rare Neurological Diseases  

Progress in understanding the genetics of epilepsies

Epilepsies affect around 65 million people worldwide and are clinically a heterogeneous group of neurological disorders. Despite strong evidence for…

more...

Created by Prof. Konrad Rejdak, Department of Neurology; Medical University of Lublin, Lublin, Poland

| Epilepsy  

Brivaracetam – a new anti-epileptic drug in Europe

Brivaracetam was approved for adjunctive treatment of partial epilepsy with focal and secondary generalised seizures by the EMEA in January 2016.…

more...

Created by Tim von Oertzen